Literature DB >> 6094930

[Thoracic and cardiovascular surgery].

P Satter.   

Abstract

In non-small cell carcinoma with lymph node involvement chemotherapy is able to improve survival as well as surgery and chemotherapy in small-cell carcinoma. In heart valve replacement with bioprosthesis change in procurement and fixation has improved 7-year survival rate from 75-95%. Modern pace makers use breathing frequency and Q-T interval from EKG to adjust cardiac output according to demand. Implantable defibrillators are able to reduce lethality in malignant arrhythmias. Acute myocardial revascularisation cannot prevent an infarct but reduce its extent. In chronic pulmonary artery obstruction endarterectomy is possible in selected cases.

Entities:  

Mesh:

Year:  1984        PMID: 6094930     DOI: 10.1007/bf01823214

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  8 in total

1.  [Pro and con: small cell bronchial cancer - surgery or chemotherapy as the primary treatment. Arguments for selective primary resection].

Authors:  D Greschuchna; W Maassen
Journal:  Internist (Berl)       Date:  1981-11       Impact factor: 0.743

2.  Reduction in local recurrence and improved survival in surgically treated patients with small cell lung cancer.

Authors:  F A Shepherd; R J Ginsberg; W K Evans; R Feld; J D Cooper; R Ilves; T R Todd; F G Pearson; P F Waters; M A Baker
Journal:  J Thorac Cardiovasc Surg       Date:  1983-10       Impact factor: 5.209

3.  Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.

Authors:  S B Newman; T R DeMeester; H M Golomb; P C Hoffman; A G Little; V Raghavan
Journal:  J Thorac Cardiovasc Surg       Date:  1983-08       Impact factor: 5.209

4.  Surgical resection in the management of small cell carcinoma of the lung.

Authors:  T W Shields; G A Higgins; M J Matthews; R J Keehn
Journal:  J Thorac Cardiovasc Surg       Date:  1982-10       Impact factor: 5.209

5.  Trials of the automatic implantable defibrillator in man. A three-year program report.

Authors:  L Watkins; M M Mower; P R Reid; E V Platia; L S Griffith; M Mirowski
Journal:  J Thorac Cardiovasc Surg       Date:  1983-09       Impact factor: 5.209

6.  Rate responsive pacing using the evoked QT principle. A physiological alternative to atrial synchronous pacemakers.

Authors:  R M Donaldson; A F Rickards
Journal:  Pacing Clin Electrophysiol       Date:  1983-11       Impact factor: 1.976

7.  Fate of a second porcine bioprosthetic valve.

Authors:  D J Magilligan; J W Lewis; R H Heinzerling; D Smith
Journal:  J Thorac Cardiovasc Surg       Date:  1983-03       Impact factor: 5.209

8.  Survival after resection of small cell carcinoma of the bronchus.

Authors:  D F Shore; M Paneth
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.